-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
4 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$19.59 M
Halozyme Therapeutics, Inc. Insider Transactions
Halozyme Therapeutics, Inc. Insider Trades History
Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
---|---|---|---|---|---|---|---|
Torley Helen
CEO |
Sell | 10,000 @ $57.95 | $579,490 | 676,744 | 08/15/2024 | 08/15/2024 | |
Torley Helen
CEO |
Sell | 3,263 @ $56.22 | $183,443 | 683,481 | 08/14/2024 | 08/15/2024 | |
Torley Helen
CEO |
Sell | 6,537 @ $57.73 | $377,394 | 676,944 | 08/14/2024 | 08/15/2024 | |
Torley Helen
CEO |
Sell | 200 @ $58.17 | $11,634 | 676,744 | 08/14/2024 | 08/15/2024 | |
Posard Matthew L.
Director |
Sell | 9,881 @ $57.70 | $570,134 | 69,874 | 08/14/2024 | 08/14/2024 | |
Torley Helen
CEO |
Sell | 10,000 @ $56.25 | $562,490 | 676,744 | 08/13/2024 | 08/15/2024 | |
Posard Matthew L.
Director |
Sell | 10,000 @ $56.19 | $561,930 | 79,755 | 08/13/2024 | 08/14/2024 | |
Posard Matthew L.
Director |
Sell | 10,000 @ $55.72 | $557,230 | 89,755 | 08/12/2024 | 08/14/2024 | |
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $55.12 | $551,150 | 168,176 | 07/24/2024 | 07/24/2024 | |
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 4,709 @ $54.46 | $256,466 | 173,467 | 07/23/2024 | 07/24/2024 | |
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 5,291 @ $55.27 | $292,407 | 168,176 | 07/23/2024 | 07/24/2024 | |
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER |
Sell | 4,008 @ $53.85 | $215,843 | 15,480 | 07/22/2024 | 07/23/2024 | |
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER |
Sell | 992 @ $54.25 | $53,819 | 15,480 | 07/22/2024 | 07/23/2024 | |
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER |
Sell | 10,000 @ $52.04 | $520,400 | 15,480 | 06/28/2024 | 06/28/2024 | |
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER |
Sell | 10,000 @ $51.93 | $519,340 | 15,480 | 06/27/2024 | 06/28/2024 | |
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER |
Sell | 10,000 @ $51.82 | $518,200 | 15,480 | 06/26/2024 | 06/28/2024 | |
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $49.43 | $494,260 | 168,176 | 06/18/2024 | 06/20/2024 | |
Posard Matthew L.
Director |
Sell | 10,000 @ $50.62 | $506,190 | 99,755 | 06/12/2024 | 06/13/2024 | |
Posard Matthew L.
Director |
Sell | 10,000 @ $50.01 | $500,110 | 109,755 | 06/11/2024 | 06/13/2024 | |
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $45.38 | $453,840 | 168,176 | 05/22/2024 | 05/22/2024 |
Halozyme Therapeutics, Inc. Congressional Trades History
Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
---|---|---|---|---|---|
$49.00 | Sale (Partial) | $1,001 - $15,000 | 10/03/2024 | 09/09/2024 |
Halozyme Therapeutics, Inc. Frequently Asked Questions
-
Who is on Halozyme Therapeutics, Inc.'s Insider Roster?
The list of insiders at Halozyme Therapeutics, Inc. includes LaBarre Michael J., Posard Matthew L., LaBrosse Nicole, Torley Helen.
-
How much insider selling is happening at Halozyme Therapeutics, Inc.?
Insiders have sold a total of 374,881 Halozyme Therapeutics, Inc. shares in the last 12 months for a total of 19.59 M sold.
-
Which Halozyme Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Halozyme Therapeutics, Inc. shares in the last 12 months: LaBarre Michael J. ($8.81 M), Posard Matthew L. ($2.70 M), LaBrosse Nicole ($1.83 M), Torley Helen ($6.26 M),